Allspring Global Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-382
Closed -$16.2K 2368
2024
Q3
$16.2K Sell
382
-7,187
-95% -$305K ﹤0.01% 2038
2024
Q2
$305K Buy
7,569
+934
+14% +$39K ﹤0.01% 1618
2024
Q1
$235K Buy
6,635
+6,237
+1,567% +$167K ﹤0.01% 1675
2023
Q4
$11.8K Buy
398
+90
+29% +$1.87K ﹤0.01% 2010
2023
Q3
$6.4K Sell
308
-82
-21% -$2.25K ﹤0.01% 2659
2023
Q2
$9.57K Sell
390
-4,087
-91% -$131K ﹤0.01% 2542
2023
Q1
$182K Sell
4,477
-3,717
-45% -$154K ﹤0.01% 1845
2022
Q4
$368K Buy
8,194
+5,611
+217% +$254K ﹤0.01% 1680
2022
Q3
$123K Sell
2,583
-114,125
-98% -$6.26M ﹤0.01% 1994
2022
Q2
$6.91M Buy
116,708
+6,975
+6% +$573K 0.01% 894
2022
Q1
$12.8M Sell
109,733
-937
-0.8% -$109K 0.02% 805
2021
Q4
$16.7M Buy
+110,670
New +$14.9M 0.02% 768

Other funds holding TNDM

Allspring Global Investments's TNDM Position: Q4 2024 in Review

Allspring Global Investments sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 382 shares — an estimated $16.2K sold.

Allspring Global Investments first reported a position in TNDM in Q4 2021 and held it in 12 quarters. The position peaked at $16.7M in Q4 2021. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • Allspring Global Investments reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 382 Tandem Diabetes Care shares in Q4 2024, an estimated $16.2K.
  • Allspring Global Investments first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Tandem Diabetes Care position peaked at $16.7M in Q4 2021.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.